docetaxel anhydrous has been researched along with dalteparin in 7 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (dalteparin) | Trials (dalteparin) | Recent Studies (post-2010) (dalteparin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 5,665 | 1,423 | 2,267 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaikin, P; Durrleman, S | 1 |
| Busby, E; Carey, DE; Marques, MB; Reynolds, RE; Robert, F | 1 |
| Amathieu, R; Dhonneur, G; Fessenmeyer, C; Tual, L | 1 |
| Allona, A; Arias, F; Burgos, J; Fernández, E; González-Martín, A; Guillén, C; López García, M; Mayayo, T; Moyano, A; Rodríguez Patrón, R; Vaz, MA | 1 |
| Hess, D; Köberle, D; Korte, W; Seeholzer, N; Thürlimann, B | 1 |
| Benson, AB; Berlin, J; Burtness, B; Catalano, P; Chapman, AE; Liles, DK; Mitchell, E; Powell, M | 1 |
4 trial(s) available for docetaxel anhydrous and dalteparin
| Article | Year |
|---|---|
Phase II study of docetaxel plus enoxaparin in chemotherapy-naive patients with metastatic non-small cell lung cancer: preliminary results.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Enoxaparin; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Taxoids; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients.
Topics: Aged; Anticoagulants; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Enoxaparin; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Taxoids; Time Factors; Treatment Outcome | 2007 |
Combining chemotherapy and low-molecular-weight heparin for the treatment of advanced breast cancer: results on clinical response, transforming growth factor-beta 1 and fibrin monomer in a phase II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Humans; Middle Aged; Taxoids; Time Factors; Transforming Growth Factor beta1 | 2007 |
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Camptothecin; Cetuximab; Diarrhea; Disease-Free Survival; Docetaxel; Enoxaparin; Female; Humans; Irinotecan; Male; Middle Aged; Pancreatic Neoplasms; Response Evaluation Criteria in Solid Tumors; Survival Rate; Taxoids; Thromboembolism | 2016 |
3 other study(ies) available for docetaxel anhydrous and dalteparin
| Article | Year |
|---|---|
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aged; Amlodipine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; BCG Vaccine; Cefotetan; Cephamycins; Contrast Media; Cysteine; Dapsone; Diltiazem; Dipyrone; Docetaxel; Drug Eruptions; Echinacea; Enoxaparin; Female; Fructose; Glucans; Glucose; Gold Sodium Thiomalate; Humans; Ibuprofen; Icodextrin; Ioxaglic Acid; Male; Middle Aged; Minocycline; Paclitaxel; Pregnancy; Solvents; Taxoids; Topiramate; Triamcinolone; Trichloroethylene | 2001 |
The use of putative placebo in active control trials: two applications in a regulatory setting.
Topics: Angina, Unstable; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase III as Topic; Confidence Intervals; Data Interpretation, Statistical; Docetaxel; Doxorubicin; Enoxaparin; Female; Fibrinolytic Agents; Humans; Myocardial Infarction; Odds Ratio; Paclitaxel; Placebos; Randomized Controlled Trials as Topic; Taxoids; Therapeutic Equivalency | 2003 |
[Docetaxel-induced acute pulmonary capillary-leak syndrome mimicking cardiogenic oedema].
Topics: Acute Disease; Anticoagulants; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Capillary Leak Syndrome; Diagnosis, Differential; Docetaxel; Dose-Response Relationship, Drug; Edema, Cardiac; Female; Heparin, Low-Molecular-Weight; Humans; Lung Neoplasms; Methylprednisolone; Middle Aged; Pulmonary Edema; Pulmonary Embolism; Recurrence; Respiration, Artificial; Spinal Neoplasms; Taxoids; Tinzaparin | 2007 |